drugset / Trial / NCT01949038

Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy

NCT01949038

Phase 2/3 Completed 220 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupTriple-blindPrevention

Summary

Diagnostic esophagogastroduodenoscopy is an uncomfortable and stressful procedure for most of the patients. Various methods are available for sedation during this procedure. Because of some side effects related to intravenous administration of sedatives, oral administration of these drugs is under attention. Alprazolam is a benzodiazepine which is used mainly in treatment of anxiety. Hence, we determine the efficacy of oral and sublingual alprazolam as for sedation during this procedure. We hypothesize that sublingual alprazolam is more effective than that oral form and both forms more effective than placebo in reducing anxiety and pain/discomfort related to the procedure.

Timeline

Start
2011-09
Primary completion
2012-10
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprazolam Small molecule 0.5 mg Oral

Indications

No indication recorded.